Stocks

Orbcomm has the potential to gain 241% over the year

Stock markets seemed to edge up lately as the coronavirus pandemic slowed in the major epicenters. Analysts warn that recovery…

4 years ago

Experts recommend Orbcomm. Why is this stock a good choice?

Orbcomm is a penny stock. Experts think that it presents an excellent opportunity for investors to get hefty profits for…

4 years ago

What caused the rally in U.S. stocks over the last days?

The U.S. stocks have been climbing up over the last few days. The S&P 500 skyrocketed by 1.5% to close…

4 years ago

U.S. futures hit high after the Fed issued a new project

The stocks are at last recovering from the long bearish period. The S&P 500 rose by 12.1%, marking its highest…

4 years ago

JNJ is working on a COVID-19 vaccine. Will it be successful?

Johnson & Johnson is a consumer goods and healthcare heavyweight, which is currently working to develop a vaccine against COVID-19.…

4 years ago

Johnson & Johnson may be imperative to defeat coronavirus

The stock markets continue to fluctuate around the world as the pandemic continues. While the coronavirus cases eased slightly in…

4 years ago

Experts recommend grabbing two penny stocks with potential

Penny stocks are often the best choice, if you can’t afford to invest big money, but want to receive hefty…

4 years ago

Zix Corporation is a strong buy. What about Plug Power?

The global economy has been in an uproar after the coronavirus outbreaks developed into a pandemic. Investors are trying to…

4 years ago

Analysts recommend buying Gilead Sciences and Abbott

Stock markets were volatile during the last months due to the coronavirus pandemic. As countries went into lockdown, most businesses…

4 years ago

Abbott has a potential to gain. What about Gilead Sciences?

Most of the stocks collapsed due to the coronavirus epidemic, as the businesses were suspended during all the countries' lockdowns.…

4 years ago

This website uses cookies.